Curatis Holding AG

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

Curatis Holding AG publishes Annual Report of the (then still named) Kinarus Group for FY2023 and announces appointment of Chief Financial Officer

Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed

Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split

Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis

Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023